EUVIMEDEUVIMED entdecken
Crossref

Carrier-free nano-prodrugs for minimally invasive cancer therapy

Keita Tanita, Yoshitaka Koseki, Sanjay Kumar, Farsai Taemaitree, Asuka Mizutani, Hirotaka Nakatsuji, Ryuju Suzuki, Anh Thi Ngoc Dao, Fumiyoshi Fujishima, Hiroshi Tada, Takanori Ishida, Ken Saijo und 2 weitere

Nanoscale · 2024 · 16 (32) · 15256-15264

DOI: 10.1039/d4nr01763c ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nanoscale, 2024. Verfasst von Keita Tanita und 13 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, 980-8577, Japan. koseki@tohoku.ac…. Hauptthemen laut MEDLINE: Prodrugs, Irinotecan, Camptothecin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SNC4DC, a dimer of SN-38 derivatives, has been synthesized. SNC4DC nanoparticles called nano-prodrugs are internalized into the cell and dissociate, and the active SN-38 is released after reduction of the S–S bond in the presence of GSH occurs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsIrinotecanCamptothecinAnimalsHumansMiceCell Line, TumorAntineoplastic AgentsNanoparticlesDrug LiberationNeoplasmsMice, Inbred BALB CMice, Nude

Substanzen

ProdrugsIrinotecanCamptothecinAntineoplastic Agents

Autor:innen und Institutionen

  • Institute of Multidisciplinary Research for Advanced Materials, Tohoku University, 2-1-1 Katahira, Aoba-ku, Sendai, 980-8577, Japan. koseki@tohoku.ac.jp.
  • Research Institute for Electronic Science, Hokkaido University, N20W10, Kita-ku, Sapporo, 001-0020, Japan.
  • Graduate School of Engineering, Nagasaki University, 1-14 Bunkyo, Nagasaki, 852-8521, Japan.
  • Department of Pathology, Tohoku University Hospital, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
  • Department of Breast and Endocrine Surgical Oncology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
  • Department of Medical Oncology, Tohoku University Hospital, 4-1 Seiryo-machi, Aoba-ku, Sendai, 980-8575, Japan.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Tanita, K., Koseki, Y., Kumar, S., Taemaitree, F., Mizutani, A., Nakatsuji, H., Suzuki, R., Dao, A. T. N., Fujishima, F., Tada, H., Ishida, T., Saijo, K., Ishioka, C., & Kasai, H. (2024). Carrier-free nano-prodrugs for minimally invasive cancer therapy. Nanoscale, 16(32), 15256-15264. https://doi.org/10.1039/d4nr01763c

Vancouver

Tanita K, Koseki Y, Kumar S, Taemaitree F, Mizutani A, Nakatsuji H, et al. Carrier-free nano-prodrugs for minimally invasive cancer therapy. Nanoscale. 2024;16(32):15256-15264. doi:10.1039/d4nr01763c

BibTeX
@article{Tanita2024,
  author = {Tanita, Keita and Koseki, Yoshitaka and Kumar, Sanjay and Taemaitree, Farsai and Mizutani, Asuka and Nakatsuji, Hirotaka and Suzuki, Ryuju and Dao, Anh Thi Ngoc and Fujishima, Fumiyoshi and Tada, Hiroshi and Ishida, Takanori and Saijo, Ken and Ishioka, Chikashi and Kasai, Hitoshi},
  title = {Carrier-free nano-prodrugs for minimally invasive cancer therapy},
  journal = {Nanoscale},
  year = {2024},
  volume = {16},
  number = {32},
  pages = {15256--15264},
  doi = {10.1039/d4nr01763c}
}
Kostenlos starten →